tiprankstipranks
Advertisement
Advertisement

TBPH Stock Latest News

TBPH Upcoming Earnings Report: What to Expect?
Pre-EarningsTBPH Upcoming Earnings Report: What to Expect?
3d ago
TBPH
Theravance Biopharma price target raised to $17 from $14 at B. Riley
PremiumThe Fly
Theravance Biopharma price target raised to $17 from $14 at B. Riley
30d ago
MNKD
TBPH
Theravance Secures Long-Term YUPELRI Patent Litigation Settlement
PremiumCompany Announcements
Theravance Secures Long-Term YUPELRI Patent Litigation Settlement
1M ago
8K
TBPH
Theravance Biopharma price target raised to $15 from $13 at TD Cowen
PremiumThe Fly
Theravance Biopharma price target raised to $15 from $13 at TD Cowen
1M ago
TBPH
Theravance Biopharma: Post‑CYPRESS Restructuring Leaves Limited Upside and Justifies Neutral Stance
PremiumRatings
Theravance Biopharma: Post‑CYPRESS Restructuring Leaves Limited Upside and Justifies Neutral Stance
2M ago
TBPH
Theravance Biopharma reports Q4 EPS $1.15, consensus $1.10
PremiumThe FlyTheravance Biopharma reports Q4 EPS $1.15, consensus $1.10
2M ago
TBPH
Theravance Biopharma options imply 3.2% move in share price post-earnings
Premium
The Fly
Theravance Biopharma options imply 3.2% move in share price post-earnings
2M ago
TBPH
Theravance Biopharma downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Theravance Biopharma downgraded to Perform from Outperform at Oppenheimer
2M ago
TBPH
Theravance Biopharma downgraded at Oppenheimer after ampreloxetine miss
PremiumThe Fly
Theravance Biopharma downgraded at Oppenheimer after ampreloxetine miss
2M ago
TBPH
Theravance Biopharma price target lowered to $15 from $27 at H.C. Wainwright
PremiumThe Fly
Theravance Biopharma price target lowered to $15 from $27 at H.C. Wainwright
2M ago
TBPH
Theravance Biopharma downgraded to Neutral from Buy at B. Riley
PremiumThe Fly
Theravance Biopharma downgraded to Neutral from Buy at B. Riley
2M ago
TBPH
Theravance Biopharma price target lowered to $21 from $40 at BTIG
PremiumThe Fly
Theravance Biopharma price target lowered to $21 from $40 at BTIG
2M ago
TBPH
Midday Fly By: Target earnings hit the mark, Elliott invests $1B in Pinterest
PremiumThe FlyMidday Fly By: Target earnings hit the mark, Elliott invests $1B in Pinterest
2M ago
CI
ZD
Theravance Biopharma falls 28% to $13.55 in pre-market trading
Premium
The Fly
Theravance Biopharma falls 28% to $13.55 in pre-market trading
2M ago
TBPH
Theravance Biopharma implements cost reduction actions after study results
Premium
The Fly
Theravance Biopharma implements cost reduction actions after study results
2M ago
TBPH
Theravance Biopharma Restructures After Ampreloxetine Trial Failure
PremiumCompany Announcements
Theravance Biopharma Restructures After Ampreloxetine Trial Failure
2M ago
8K
TBPH
Theravance Biopharma trading resumes
PremiumThe Fly
Theravance Biopharma trading resumes
2M ago
TBPH
Theravance Biopharma says Phase 3 CYPRESS Study did not meet primary endpoint
PremiumThe Fly
Theravance Biopharma says Phase 3 CYPRESS Study did not meet primary endpoint
2M ago
TBPH
Theravance Biopharma winding down ampreloxetine program after Phase 3 results
PremiumThe Fly
Theravance Biopharma winding down ampreloxetine program after Phase 3 results
2M ago
TBPH
Theravance Biopharma trading halted, news pending
PremiumThe FlyTheravance Biopharma trading halted, news pending
2M ago
TBPH
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
BTQ
IRE
Theravance Biopharma price target raised to $27 from $20 at H.C. Wainwright
Premium
The Fly
Theravance Biopharma price target raised to $27 from $20 at H.C. Wainwright
2M ago
TBPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >